Cargando…
Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649803/ https://www.ncbi.nlm.nih.gov/pubmed/36357373 http://dx.doi.org/10.1038/s41419-022-05405-4 |
| _version_ | 1784827876439228416 |
|---|---|
| author | Qu, Kai Wang, Zhixin Fan, Haining Li, Juan Liu, Jie Li, Pingping Liang, Zheyong An, Hongli Jiang, Yina Lin, Qiushi Dong, Xiaoqun Liu, Peijun Liu, Chang |
| author_facet | Qu, Kai Wang, Zhixin Fan, Haining Li, Juan Liu, Jie Li, Pingping Liang, Zheyong An, Hongli Jiang, Yina Lin, Qiushi Dong, Xiaoqun Liu, Peijun Liu, Chang |
| author_sort | Qu, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9649803 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96498032022-11-15 Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma Qu, Kai Wang, Zhixin Fan, Haining Li, Juan Liu, Jie Li, Pingping Liang, Zheyong An, Hongli Jiang, Yina Lin, Qiushi Dong, Xiaoqun Liu, Peijun Liu, Chang Cell Death Dis Correction Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9649803/ /pubmed/36357373 http://dx.doi.org/10.1038/s41419-022-05405-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Qu, Kai Wang, Zhixin Fan, Haining Li, Juan Liu, Jie Li, Pingping Liang, Zheyong An, Hongli Jiang, Yina Lin, Qiushi Dong, Xiaoqun Liu, Peijun Liu, Chang Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title | Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title_full | Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title_fullStr | Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title_full_unstemmed | Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title_short | Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| title_sort | correction to: mcm7 promotes cancer progression through cyclin d1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649803/ https://www.ncbi.nlm.nih.gov/pubmed/36357373 http://dx.doi.org/10.1038/s41419-022-05405-4 |
| work_keys_str_mv | AT qukai correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT wangzhixin correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT fanhaining correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT lijuan correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT liujie correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT lipingping correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT liangzheyong correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT anhongli correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT jiangyina correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT linqiushi correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT dongxiaoqun correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT liupeijun correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma AT liuchang correctiontomcm7promotescancerprogressionthroughcyclind1dependentsignalingandservesasaprognosticmarkerforpatientswithhepatocellularcarcinoma |